Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients

Clinical trial NCT05292872 · COMPLETED

Trial details

NCT number: NCT05292872
Sponsor: Intercept Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Primary Biliary Cholangitis

Start date: 2015-06-01
Primary completion: 2021-12-31
Enrollment: 4577

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.